Engineering of Neutrophil Membrane Camouflaging Nanoparticles Realizes Targeted Drug Delivery for Amplified Antitumor Therapy

TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies

(2020) Hassan Dianat-Moghadam et al.   PHARMACOLOGICAL RESEARCH

Engineering antigen as photosensitiser nanocarrier to facilitate ROS triggered immune cascade for photodynamic immunotherapy

(2020) Huaiji Wang et al.   BIOMATERIALS

Rational Design of Cancer Nanomedicine for Simultaneous Stealth Surface and Enhanced Cellular Uptake

(2019) Qiao Jin et al.   ACS Nano

Neutrophil Membrane-Derived Nanovesicles Alleviate Inflammation To Protect Mouse Brain Injury from Ischemic Stroke

(2019) Xinyue Dong et al.   ACS Nano

TRAIL-based gene delivery and therapeutic strategies

(2019) Hui-hai Zhong et al.   ACTA PHARMACOLOGICA SINICA

The TRAIL to cancer therapy: Hindrances and potential solutions

(2019) Sonia How Ming Wong et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Recent advance of erythrocyte-mimicking nanovehicles: From bench to bedside

(2019) Jielai Yang et al.   JOURNAL OF CONTROLLED RELEASE

Smart cancer nanomedicine

(2019) Roy van der Meel et al.   Nature Nanotechnology

Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy

(2018) Pedro P.G. Guimarães et al.   ACS Nano

Cell Membrane Coated Semiconducting Polymer Nanoparticles for Enhanced Multimodal Cancer Phototheranostics

(2018) Jingchao Li et al.   ACS Nano

Recent Advances in Cell Membrane-Camouflaged Nanoparticles for Cancer Phototherapy

(2018) Xu Zhen et al.   Small

MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma

(2018) Meiying Wu et al.   Nature Communications

TRAIL–NP hybrids for cancer therapy: a review

(2017) H. Belkahla et al.   Nanoscale

Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence

(2017) Jingwei Xue et al.   Nature Nanotechnology

Safety and tolerability of TRAIL receptor agonists in cancer treatment

(2015) Simone Fulda   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy

(2015) Xiaoyun Dai et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Principles of nanoparticle design for overcoming biological barriers to drug delivery

(2015) Elvin Blanco et al.   NATURE BIOTECHNOLOGY

Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance

(2015) Lang Rao et al.   Small

Gel-Liposome-Mediated Co-Delivery of Anticancer Membrane-Associated Proteins and Small-Molecule Drugs for Enhanced Therapeutic Efficacy

(2014) Tianyue Jiang et al.   ADVANCED FUNCTIONAL MATERIALS

Novel Conjugation of Tumor-Necrosis-Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Monomethyl Auristatin E for Efficient Antitumor Drug Delivery

(2013) Li-Qiang Pan et al.   ADVANCED MATERIALS

Getting Leukocytes to the Site of Inflammation

(2013) W. A. Muller   VETERINARY PATHOLOGY

PLGA-based nanoparticles: An overview of biomedical applications

(2012) Fabienne Danhier et al.   JOURNAL OF CONTROLLED RELEASE

Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types

(2011) Sungho Bae et al.   BIOMATERIALS